Invesaro

Stocks SILO Earnings

Earnings

Silo Pharma, Inc. (SILO) earnings

Quarterly results of Silo Pharma, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when SILO files with the SEC.

Next earnings date

Silo Pharma, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Silo Pharma, Inc. reported revenue of - and a net loss of $832.8K.

Diluted earnings per share were -$0.76.

Filed with the SEC on August 13, 2026.

Revenue by quarter
Q3 24: $18K $18K Q3 24Q4 24: $18K $18K Q4 24Q1 25: $18K $18K Q1 25Q2 25: $18K $18K Q2 25Q3 25: $18K $18K Q3 25Q4 25: $18K $18K Q4 25Q1 26: $18K $18K Q1 26
Net income by quarter
Q3 24: -$928.8K -$928.8K Q3 24Q4 24: -$1.7M -$1.7M Q4 24Q1 25: -$1M -$1M Q1 25Q2 25: -$1.2M -$1.2M Q2 25Q3 25: -$1.1M -$1.1M Q3 25Q4 25: -$881.5K -$881.5K Q4 25Q1 26: -$1.6M -$1.6M Q1 26Q2 26: -$832.8K -$832.8K Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026---$832.8K-$0.76
Q1 FY2026March 31, 2026$18K+0%-$1.6M-$0.12
Q4 FY2025December 31, 2025$18K+0%-$881.5K-
Q3 FY2025September 30, 2025$18K+0%-$1.1M-$0.12
Q2 FY2025June 30, 2025$18K--$1.2M-$2.88
Q1 FY2025March 31, 2025$18K--$1M-$0.23
Q4 FY2024December 31, 2024$18K--$1.7M-
Q3 FY2024September 30, 2024$18K--$928.8K-$0.22

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Silo Pharma, Inc.'s next earnings date?

Silo Pharma, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when SILO reports

Follow SILO and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when SILO files with the SEC.

Source: quarterly figures Silo Pharma, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Silo Pharma, Inc.